image
Castle Biosciences, Inc. CSTL
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 28.1
-8.86 %
$ 787 M
Market Cap
133.81
P/E
BALANCE SHEET
453 M ASSETS
1.34%
Growth Rates
1Year 1.34%
3Years 1.05%
5Years 82.48%
7Years 0.00%
10Years 0.00%
62.1 M LIABILITIES
28.83%
Growth Rates
1Year 28.83%
3Years 37.96%
5Years 13.83%
7Years 0.00%
10Years 0.00%
391 M EQUITY
-1.97%
Growth Rates
1Year -1.97%
3Years -2.00%
5Years 110.02%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Castle Biosciences, Inc.
image
Current Assets 296 M
Cash & Short-Term Investments 243 M
Receivables 38.3 M
Other Current Assets 14.2 M
Non-Current Assets 158 M
Long-Term Investments 0
PP&E 37.7 M
Other Non-Current Assets 120 M
Current Liabilities 47.7 M
Accounts Payable 10.3 M
Short-Term Debt 2.27 M
Other Current Liabilities 35.1 M
Non-Current Liabilities 14.4 M
Long-Term Debt 14.2 M
Other Non-Current Liabilities 206 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 98.8 122.9 329.6 409.9 98.8 4.5 1.2
Short Term Investments 144.3 135.7 0 0 0 0 0
Receivables 38.3 23.5 17.3 12.8 14.6 12.1 4.7
Inventory 7.9 4.0 2.0 2.2 1.2 0.9 0.3
Other Current Assets 6.3 6.2 9.6 9.5 3.9 0.7 0.5
Total Current Assets 295.6 292.3 353.7 429.6 116.7 18.1 6.7
PP&E 37.7 26.5 16.9 7.1 2.1 1.5 1.5
Intangible Assets 106.6 115.7 88.9 0 0 4.17 K 40.1 K
Goodwill 10.7 10.7 0 0 0 0 0
Long Term Investments 0 1.1 1.3 1.1 0.9 2.5 1.6
Other Long Term Assets 2.6 (25.6) 3.0 1.5 0.1 2.7 1.6
Other Assets 0 0 0 0 0 0 0
Total Assets 453.3 447.3 462.6 439.3 119.7 22.4 9.8
LIABILITIES
Accounts Payable 10.3 4.7 2.5 2.1 1.9 1.5 1.1
Short Term Debt 2.3 3.6 2.4 0 5.8 0 1.0
Other Current Liabilities 35.1 27.8 19.3 12.1 7.5 5.3 3.1
Total Current Liabilities 47.7 36.1 24.9 20.9 15.3 6.7 5.2
Long Term Debt 14.2 11.5 6.9 0 19.3 24.5 17.6
Deferred Tax Income 0.2 0.4 0.6 0 0 0 0
Other Liabilities 0 90 K 18.4 1.0 55 K 1.2 1.3
Total Liabilities 62.1 48.2 50.8 23.6 34.6 32.5 24.1
EQUITY
Common Stock 27 K 27 K 25 K 25 K 17 K 1.92 K 1.9 K
Retained Earnings (218.4) (160.9) (93.8) (62.5) (52.2) (57.5) (51.1)
Other Accumulative Comprehensive Income/Loss 0.1 (0.4) 0 0 (119.7) (0.9) (0.6)
Total Equity 391.3 399.1 411.7 415.7 85.1 (10.1) (14.3)
Total Liabilities and Equity 453.3 447.3 462.6 439.3 119.7 22.4 9.8
SHARES OUTSTANDING
Common Shares Outstanding 26.8 26.1 25.1 18.9 8.6 10.7 9.8